These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9185106

  • 1. Sodium and water retention in heart failure: pathogenesis and treatment.
    Martin PY, Schrier RW.
    Kidney Int Suppl; 1997 Jun; 59():S57-61. PubMed ID: 9185106
    [Abstract] [Full Text] [Related]

  • 2. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
    Schrier RW.
    Am J Med; 2006 Jul; 119(7 Suppl 1):S47-53. PubMed ID: 16843085
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis of water and sodium retention in cirrhosis.
    Martin PY, Schrier RW.
    Kidney Int Suppl; 1997 Jun; 59():S43-9. PubMed ID: 9185104
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis.
    Schrier RW, Gurevich AK, Cadnapaphornchai MA.
    Semin Nephrol; 2001 Mar; 21(2):157-72. PubMed ID: 11245778
    [Abstract] [Full Text] [Related]

  • 5. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K.
    Am J Cardiol; 2005 May 02; 95(9A):8B-13B. PubMed ID: 15847852
    [Abstract] [Full Text] [Related]

  • 6. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M, Polónia J, Brandão F, Ramalhão C, da Faria DB.
    Rev Port Cardiol; 2001 May 02; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [Abstract] [Full Text] [Related]

  • 7. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy.
    Schrier RW, Fassett RG, Ohara M, Martin PY.
    Proc Assoc Am Physicians; 1998 May 02; 110(5):407-11. PubMed ID: 9756091
    [Abstract] [Full Text] [Related]

  • 8. Edematous disorders: pathophysiology of renal sodium and water retention and treatment with diuretics.
    Abraham WT, Schrier RW.
    Curr Opin Nephrol Hypertens; 1993 Sep 02; 2(5):798-805. PubMed ID: 7922221
    [Abstract] [Full Text] [Related]

  • 9. [Mechanisms of renal retention of sodium and water in heart failure, cirrhosis and pregnancy].
    Knotek M, Rogachev B, Ohara M, Schrier RW.
    Lijec Vjesn; 2000 Sep 02; 122(1-2):20-6. PubMed ID: 10916353
    [Abstract] [Full Text] [Related]

  • 10. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C, Cargnoni A, Curello S, Ferrari R.
    Rev Port Cardiol; 1998 Oct 02; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [Abstract] [Full Text] [Related]

  • 11. [Neurohumoral regulation in heart failure].
    Riegger GA, Muders F, Luchner A.
    Z Kardiol; 1996 Oct 02; 85 Suppl 6():205-10. PubMed ID: 9064967
    [Abstract] [Full Text] [Related]

  • 12. Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia.
    Schrier RW, Briner VA.
    Obstet Gynecol; 1991 Apr 02; 77(4):632-9. PubMed ID: 2002992
    [Abstract] [Full Text] [Related]

  • 13. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J, Pereira M, Castro A, Dias P, Azevedo A, Bettencourt P, Ferreira A.
    Rev Port Cardiol; 2002 Feb 02; 21(2):157-62. PubMed ID: 11963285
    [Abstract] [Full Text] [Related]

  • 14. [The physiopathological aspects and new therapeutic approaches in cardiac-circulatory failure].
    Peruzzi G, Di Nardo P, Raimondi G, Legramante JM, Iellamo F, Massaro M, Bellegrandi F, Minieri M, Pafi M, Castrucci F.
    Clin Ter; 1992 Nov 02; 141(11):339-72. PubMed ID: 1493659
    [Abstract] [Full Text] [Related]

  • 15. Body fluid volume regulation in health and disease.
    Abraham WT, Schrier RW.
    Adv Intern Med; 1994 Nov 02; 39():23-47. PubMed ID: 8140955
    [Abstract] [Full Text] [Related]

  • 16. Alterations in renal function in experimental congestive heart failure.
    Awazu M, Ichikawa I.
    Semin Nephrol; 1994 Sep 02; 14(5):401-11. PubMed ID: 7997647
    [Abstract] [Full Text] [Related]

  • 17. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
    Ferreira A, Bettencourt P, Dias P, Pestana M, Serrão P, Soares-da-Silva P, Cerqueira-Gomes M.
    Clin Sci (Lond); 2001 May 02; 100(5):557-66. PubMed ID: 11294697
    [Abstract] [Full Text] [Related]

  • 18. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A.
    Pharmacol Ther; 2004 Jun 02; 102(3):223-41. PubMed ID: 15246247
    [Abstract] [Full Text] [Related]

  • 19. [Progress in management for heart failure: diuretics].
    Aoyagi T, Hirata Y.
    Nihon Rinsho; 1993 May 02; 51(5):1281-6. PubMed ID: 8331795
    [Abstract] [Full Text] [Related]

  • 20. Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.
    Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Suzuki K, Kodama M, Aizawa Y.
    Biochem Pharmacol; 2007 Nov 15; 74(10):1466-75. PubMed ID: 17720144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.